Medtronic pain inverventions
At Medtronic, we join together to deliver the highest level of medical education and technical expertise, experience, and excellence alongside dedicated and reliable clinical support. This means you can focus on what matters most — ensuring that your patients can live richer, more vibrant lives.
When pain persists, insist on Medtronic — with one of the broadest product portfolios in the industry. Learn more about our portfolio of pain solutions.
Spinal cord stimulation
Discover the latest technological advancements in spinal cord stimulators (SCS) for patients with intractable pain, including painful diabetic peripheral neuropathy (DPN). Learn how we engineer products with full-body MRI access in mind.†
Targeted drug delivery
Targeted drug delivery (TDD) infuses medication directly into the intrathecal space, providing effective pain relief while helping to reduce or eliminate systemic opioids. Learn how TDD can reduce the amount of medication required to effectively manage chronic pain, cancer pain, and severe spasticity. Intrathecal drug delivery enables patients to experience effective relief at a fraction of the systemic dose, which can reduce side effects.1-3
Intrathecal drug delivery enables patients to experience pain relief using a fraction of an oral medication dose.1,4,5
Radiofrequency (RF) ablation for bone tumors
The OsteoCool™ 2.0 system is an internally-cooled radiofrequency (RF) ablation system with four-probe capability to palliatively treat painful bone tumors.
Vertebral augmentation
Restore height and relieve pain.6
Kyphon™ balloon kyphoplasty (BKP) is used to treat pathological fractures of the vertebral body due to osteoporosis, cancer, or benign lesions.
Accurian™ RF ablation for nerve tissue
The Accurian™ radiofrequency (RF) nerve tissue ablation platform delivers consistent and predictable lesions and smart features for ease of use.
Featured products
Products
† Under specific conditions. Refer to product labeling for full list of conditions. Patients with non-Medtronic leads and an EMBSNV20 adaptor extension are not eligible for an MRI.
- Hamza, M et al. Prospective Study of 3-Year Follow-Up of Low-Dose Intrathecal Opioids in the Management of Chronic Nonmalignant Pain. Pain Medicine. (United States) 13, 1304–1313 (2012).
- Smith, TJ et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug-related toxicity, and survival. Journal of Clinical Oncology. 20, 4040–4049 (2002).
- Rushton, DN. Upper Motor Neurone Syndrome and Spasticity: Chapter 10 Intrathecal Baclofen for the Control of Spinal and Supraspinal Spasticity. ed. Barnes, MP and Johnson, GR pages 181–192. (Cambridge University Press, 2008). doi:10.1017/cbo9780511544866.011.
- Grider JS, Harned ME, Etscheidt MA. Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain, Pain Physician 2011; 14:343–351.
- Ruan X. Drug-related side effects of long-term intrathecal morphine therapy. Pain Physician. 2007;10:357–366.
- Van Meirhaeghe J, Bastian L, Boonen S, et al. A randomized trial of balloon kyphoplasty and nonsurgical management for treating acute vertebral compression fractures: vertebral body kyphosis correction and surgical parameters. Spine (Phila Pa 1976). 2013;38(12):971–983.